Establishment and characteristics of two syngeneic human osteosarcoma cell lines from primary tumor and skip metastases
Abstract
Aim To characterize and compare the different biological behaviors of 2 novel human osteosarcoma cell lines, Zos and Zos-M, established respectively from the primary tumor and the skip metastasis of an osteosarcoma patient. Methods In vitro studies included morphological observations, karyotype analysis, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cell proliferation assay, and cell sensitivity to chemotherapeutic drugs. Subcutaneous and intravenous inoculations into nude mice were carried out to study the tumorigenicity and the metastatic potential. RT-PCR was performed to assess the expression of the osteoblastic markers and some metastasis-related genes. Results Both cell lines remained stable for more than 100 passages in vitro without interruption. The RT-PCR examination indicated that they retained the molecular characteristics of an osteoblastic lineage. The karyotype analysis displayed aneuploidy and various structural abnormalities. Both cell lines are tumorigenic; Zos-M differs from Zos by the former's ability to develop lung metastasis after intravenous injection. The comparison of the expression patterns of some metastasis-related genes revealed that the decreased expression of cadherin-11 in Zos-M may correlate with a high potential of metastases. Moreover, both cell lines are less sensitive to the current chemotherapy protocols. Conclusion The establishment of osteosarcoma cell lines, Zos and Zos-M, and related animal models provide a useful reso…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Zos and Zos-M were established respectively from the primary tumor site and the skip metastasis of an osteosarcoma patient.
“Similarly, Zos and Zos-M were established respectively from the primary tumor site and the skip metastasis of an osteosarcoma patient [14].”
From Investigation of Cross-Contamination and Misidentification of 278 Widely Used Tumor Cell Lines (2017) · cites this paper as [14]
Cites
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Investigation of Cross-Contamination and Misidentification of 278 Widely Used Tumor Cell Lines
Huang, Y., Liu, Y., Zheng, C., & Shen, C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170384 · Cited by 105 · see citing works
- Authors
- ZOU, C.-Y., WANG, J., SHEN, J.-N., HUANG, G., JIN, S., YIN, J.-Q., GUO, Q.-C., LI, H.-M., LUO, L., ZHANG, M., & ZHANG, L.-J.
- Affiliations
- Sun Yat-sen University (CN)
- Venue
- Acta Pharmacologica Sinica
- Published
- 2008-03
- Volume
- 29
- Issue
- 3
- Pages
- 325-332
- ISSN
- 0253-9756 (ISSN-L)
- 1671-4083
- 1745-7254
- OpenAlex
- W2037396413
- Cited by
- 37
- References
- 1
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 5 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 2 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 2
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Acta Pharmacologica Sinica (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (30200285)
- Sun Yat-sen University
- University of Texas MD Anderson Cancer Center
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoma Diagnosis and Treatment
- Health Sciences › Medicine › Rheumatology › Bone Tumor Diagnosis and Treatments
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- osteosarcoma, skip metastasis, lung metastasis, cadherin-11, chemoresistance, tumorigenicity, metastasis-related gene expression, nude mouse xenograft
- MeSH terms
- Adolescent, Animals, Antimetabolites, Antineoplastic, Collagen, Drug Combinations, Extracellular Matrix, Formazans, Humans, Karyotyping, Laminin, Male, Methotrexate, Mice, Nude, Neoplasm Metastasis, Proteoglycans, Osteosarcoma, Tetrazolium Salts, Biomarkers, Tumor, Cell Lineage, Inhibitory Concentration 50, Xenograft Model Antitumor Assays, Cell Line, Tumor, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review